podcast_episode / 1d ago
<p>Perhaps the tools to face death— heal from trauma— and transform life—have been within us all along.</p> <p>In this special episode of Alive Again, host Dan Bush sits down with Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS) and one of the most influential voices in psychedelic research today. Together, they explore how psychedelic-assisted therapy is changing the landscape of trauma recovery, end-of-life care, and the very nature of what it means to heal.</p> <p>Rick shares insights from decades of groundbreaking work using MDMA, LSD, and psilocybin in clinical settings—particularly for thos...
news_article / 1d ago
Psychedelic renaissance may take longer than expected - The Denver Post
news_article / 1d ago
Remembering Beckley Foundation Founder, Amanda Feilding (1943–2025) - Multidisciplinary Association for Psychedelic Studies – MAPS
news_article / 1d ago
Texas is leading psychedelic research for treating addiction, mental illness. Where is California? - San Francisco Chronicle
news_article / 1d ago
MAPS Brings MDMA-Assisted Therapy to the War in Ukraine - lucid.news
news_article / 1d ago
Our Biggest Takeaways from Psychedelic Science 2025 - 5280
news_article / 1d ago
In Photos: The Psychedelics Science conference wrapped last week. Here’s who we met - Colorado Public Radio
news_article / 1d ago
How Elon Musk’s billionaire Doge lieutenant took over the US’s biggest MDMA company - The Guardian
news_article / 1d ago
Could a lesser-known psychedelic drug be the next therapy? - Pittsburgh Post-Gazette
news_article / 1d ago
Reading The FDA Tea Leaves On Psychedelics - Life Science Leader
news_article / 1d ago
[Watch] Rick Doblin: ‘We Taxed Ecstasy Dealers To Fund Our DEA Lawsuit’ - High Times Magazine
news_article / 1d ago
With Lykos MDMA Rejection Letter Out, MAPS Founder Decries ‘Change of the Goal Posts’ - BioSpace
news_article / 1d ago
RFK Jr. suggests psychedelic therapy for depression and trauma has Trump administration's support - PBS
news_article / 1d ago
Rick Doblin, PhD, Weighs in on the FDA CRL for MDMA-Assisted Therapy - Psychiatric Times